Predictive factors of major low anterior resection syndrome after surgery for rectal tumors.

Q3 Medicine
Mehdi Trabelsi, Imen Samaali, Neirouz Kammoun, Amine Ben Safta, Annouar Oueslati, Wejih Dougaz, Mehdi Khalfallah, Hichem Jerraya, Ibtissem Bouasker, Ramzi Nouira, Chadli Dziri
{"title":"Predictive factors of major low anterior resection syndrome after surgery for rectal tumors.","authors":"Mehdi Trabelsi, Imen Samaali, Neirouz Kammoun, Amine Ben Safta, Annouar Oueslati, Wejih Dougaz, Mehdi Khalfallah, Hichem Jerraya, Ibtissem Bouasker, Ramzi Nouira, Chadli Dziri","doi":"10.62438/tunismed.v102i10.5177","DOIUrl":null,"url":null,"abstract":"<p><strong>Aim: </strong>To describe the epidemiological and clinical data of impaired functional outcome secondary to anterior resection of the rectum and to identify the predictive factors of major low anterior resection syndrome (LARS) Methods: This retrospective study considered patients operated on for rectal tumors in surgical department in our hospital, between January 1st,2009 and December 31st, 2021. The primary outcome measure was the development of a major LARS immediately or after stoma closure. In order to identify independent predictors of major LARS, patients were divided into two groups: the \"Major LARS\" group and the \"No Major LARS\" group, and then we carried out a descriptive study, followed by an analytical study with logistic regression.</p><p><strong>Results: </strong>We enrolled 42 patients operated for rectal tumor and had an anterior resection. Half of our patients developed LARS of which 14 developed major LARS. The median time to onset of LARS symptoms was 9 [2 -24] months. At the end of this study, 2 factors were retained: age (OR=2.48; CI95% [1.2- 5.10], p=0.012) and pT3T4 stage (OR=5.95; CI95% [1.07- 33.33], p=0.041) as independent predictive factors of a major LARS. Neoadjuvant therapy was also a risk factor for major LARS in our study with a statistically significant difference (p=0.025) between the two groups \"Major LARS\" and \"No major LARS\".</p><p><strong>Conclusion: </strong>LARS should be appropriately considered in the management of rectal cancer. Based on our results and data from the literature, age and mesorectal invasion were found to be independent predictors of major LARS.</p>","PeriodicalId":38818,"journal":{"name":"Tunisie Medicale","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2024-10-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Tunisie Medicale","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.62438/tunismed.v102i10.5177","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Aim: To describe the epidemiological and clinical data of impaired functional outcome secondary to anterior resection of the rectum and to identify the predictive factors of major low anterior resection syndrome (LARS) Methods: This retrospective study considered patients operated on for rectal tumors in surgical department in our hospital, between January 1st,2009 and December 31st, 2021. The primary outcome measure was the development of a major LARS immediately or after stoma closure. In order to identify independent predictors of major LARS, patients were divided into two groups: the "Major LARS" group and the "No Major LARS" group, and then we carried out a descriptive study, followed by an analytical study with logistic regression.

Results: We enrolled 42 patients operated for rectal tumor and had an anterior resection. Half of our patients developed LARS of which 14 developed major LARS. The median time to onset of LARS symptoms was 9 [2 -24] months. At the end of this study, 2 factors were retained: age (OR=2.48; CI95% [1.2- 5.10], p=0.012) and pT3T4 stage (OR=5.95; CI95% [1.07- 33.33], p=0.041) as independent predictive factors of a major LARS. Neoadjuvant therapy was also a risk factor for major LARS in our study with a statistically significant difference (p=0.025) between the two groups "Major LARS" and "No major LARS".

Conclusion: LARS should be appropriately considered in the management of rectal cancer. Based on our results and data from the literature, age and mesorectal invasion were found to be independent predictors of major LARS.

直肠肿瘤术后主要低位前切除综合征的预测因素。
目的:描述直肠前切除术后功能受损的流行病学和临床数据,并确定主要低位前切除综合征(LARS)的预测因素 方法:这项回顾性研究考虑了 2009 年 1 月 1 日至 2021 年 12 月 31 日期间在我院外科接受直肠肿瘤手术的患者:这项回顾性研究的对象是2009年1月1日至2021年12月31日期间在我院外科接受直肠肿瘤手术的患者。主要结果指标是在造口关闭时或关闭后出现严重的 LARS。为了确定重度LARS的独立预测因素,我们将患者分为两组:"重度LARS "组和 "无重度LARS "组,然后进行了描述性研究,接着进行了逻辑回归分析研究:我们共收治了42名直肠肿瘤手术患者,他们都接受了前方切除术。半数患者发展为 LARS,其中 14 例发展为严重 LARS。出现 LARS 症状的中位时间为 9 [2 -24] 个月。本研究最后保留了两个因素:年龄(OR=2.48;CI95% [1.2-5.10],p=0.012)和pT3T4分期(OR=5.95;CI95% [1.07-33.33],p=0.041),作为严重LARS的独立预测因素。在我们的研究中,新辅助治疗也是导致重大 LARS 的风险因素,"重大 LARS "和 "无重大 LARS "两组之间的差异有统计学意义(p=0.025):结论:在治疗直肠癌时,应适当考虑 LARS。根据我们的研究结果和文献数据,我们发现年龄和直肠系膜侵犯是主要 LARS 的独立预测因素。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Tunisie Medicale
Tunisie Medicale Medicine-Medicine (all)
CiteScore
1.00
自引率
0.00%
发文量
72
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信